drugset / Trial / NCT05754840
CANnabinoids in Pediatric ONCology
Phase 1/2
Recruiting
60 enrolled
University of Manitoba
Canadian Cancer Society (CCS) · collabCanadian Institutes of Health Research (CIHR) · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
CANnabinoids in Pediatric ONCology is a randomized, double blind, adaptive clinical trial looking at the tolerability of cannabinoids in children with cancer across 3 Canadian children's hospitals.
Timeline
- Start
- 2025-07-18
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MPL-001 | Traditional medicine (herbal / TCM) | — | — |
| Subject | MPL-005 | Traditional medicine (herbal / TCM) | — | — |
| Subject | MPL-009 | Traditional medicine (herbal / TCM) | — | — |